Copyright
©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3238-3247
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3238
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3238
Table 1 Patient characteristics
Characteristics | Pharmaceutical group (n = 45) | Non-pharmaceutical group (n = 45) | t value | P value |
Sex, n (%) | 0.653 | 0.419 | ||
Male | 35 (77.78) | 38 (84.45) | ||
Female | 10 (22.22) | 7 (15.55) | ||
Age (yr, mean) | 6-18 (9.03 ± 1.78) | 6-18 (9.23 ± 1.65) | 0.553 | 0.582 |
Duration of disease (mo, mean) | 11-35 (23.89 ± 1.77) | 11-37 (23.48 ± 2.13) | 0.993 | 0.323 |
Wechsler intelligence score (score, mean) | ≥ 85 (90.23 ± 2.91) | ≥ 85 (90.37 ± 2.75) | 0.235 | 0.815 |
School, n (%) | 0.720 | 0.396 | ||
Urban | 39 (86.67) | 36 (80.00) | ||
Non-urban | 6 (13.33) | 9 (20.00) |
- Citation: Lv YB, Cheng W, Wang MH, Wang XM, Hu YL, Lv LQ. Effect of non-pharmacological treatment on the full recovery of social functioning in patients with attention deficit hyperactivity disorder. World J Clin Cases 2023; 11(14): 3238-3247
- URL: https://www.wjgnet.com/2307-8960/full/v11/i14/3238.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i14.3238